HealthMore in Health→
Engineered stem cells reverse new-onset type 1 diabetes in mice
Key Takeaways
- A MUSC team reported reversal of new-onset type 1 diabetes in mice.
- The cells were engineered to withstand inflammation better than standard MSCs.
- Human translation remains uncertain but the mechanism is clinically relevant.
DE
DT Editorial Team··via medicalxpress.com
